Skip to main content

Chapters

Transcript

Video

Multiple Myeloma: Cutting-Edge Induction and Maintenance Therapies Lead to Improved Response Rates and Survival for Newly Diagnosed Patients

Take a deep dive into therapy options for newly diagnosed myeloma patients: whether three drugs are better than two, the case for lenalidomide maintenance therapy, the many improvements in induction treatment, the future of immunotherapy, and more.

Published

May 23, 2018

Created by

UCSF MedConnection

Related Presenters

Nina Shah, MD

Hematologist-oncologist

View full profile

Related Videos

Advances (and Uncertainties) in Oncology: Current and Future Roles of Antibody Drug Conjugates

Advances (and Uncertainties) in Oncology: Current and Future Roles of Antibody Drug Conjugates

Focusing on common bladder, lung and breast cancers, three UCSF oncologists describe how antibody drug conjugates (ADCs) are changing the treatment landscape, especially for refractory cases

New Keys to Cancer Care: How 2023 Findings Impact Treatment Decisions

New Keys to Cancer Care: How 2023 Findings Impact Treatment Decisions

These four collaborative talks from UCSF and John Muir Health specialists shine a light on recent study results that should inform treatment planning for patients with a variety of GI, breast, lung and blood cancers.

Integrative Approaches to Symptom Management for Cancer Patients

Integrative Approaches to Symptom Management for Cancer Patients

This presentation from a variety of UCSF specialists covers a range of practical topics, from how clinicians can easily meet the new DEA educational requirement for opioid use disorder to the current evidence on mindfulness meditation's ...

Focused Cancer Updates: Neoadjuvant Therapy for Breast Cancer and Managing Immunotherapy Toxicity

Focused Cancer Updates: Neoadjuvant Therapy for Breast Cancer and Managing Immunotherapy Toxicity

An expert panel delivers news to inform therapy and monitoring decisions, including a look at how the I-SPY 2 trial is accelerating evaluation of promising agents in high-risk breast cancer.

Advances in Breast Cancer Care: Individualized Screening, Treatments and Follow-Up

Advances in Breast Cancer Care: Individualized Screening, Treatments and Follow-Up

Karen Goodwin, DO, covers everything from how to answer patients’ questions on mammogram frequency to how to counsel them on breast cancer prevention.

CAR T-Cells for Hematologic Malignancies and Beyond

CAR T-Cells for Hematologic Malignancies and Beyond

In this data-drenched discussion, UCSF specialists review how CAR T-cells are being used in hematologic malignancies, including aggressive lymphoma and difficult-to-treat myeloma, as well as for solid tumors, and reveal what's on the horizon ...

Better Cancer Care: Pearls From the Best Studies of 2022

Better Cancer Care: Pearls From the Best Studies of 2022

Focusing on blood, breast and lung cancers, our specialists deliver exciting findings from the latest phase III trials.

Cutting-Edge Approaches to Prostate and Breast Cancers: Reach the Right Decision for Each Patient

Cutting-Edge Approaches to Prostate and Breast Cancers: Reach the Right Decision for Each Patient

In this grand rounds presentation, you’ll learn the best risk assessment tools for prostate cancer patients, the latest surgical techniques, such as fluorescence imaging and high-intensity focused ultrasound, and tests that allow for matching ...

Cutting-Edge Cancer Care: New Approaches to Tricky Tumors

Cutting-Edge Cancer Care: New Approaches to Tricky Tumors

UCSF specialists report from the front lines of treatment for neuroendocrine tumors, pancreatic cancer and sarcomas.

Additional Links

U.S. News Honor Roll Best Hospitals 22-23

This Video Content is available for informational and educational purposes only. UCSF does not make any representation or warranties with respect to the accuracy, applicability, fitness, or completeness of the Video Content. The Regents of the University of California and its officers, agents or employees (UCSF) will not be liable for any damages of any kind arising from any use of the Video Content, which is provided as is, and without warranties. The Video Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on the Site.

©2002 - 2024 The Regents of The University of California